Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Karyopharm Therapeutics Inc (NASDAQ:KPTI)

9.34
Delayed Data
As of Jul 21
 -0.04 / -0.43%
Today’s Change
6.27
Today|||52-Week Range
14.63
-0.64%
Year-to-Date
No recent news for Karyopharm Therapeutics Inc.

Today’s Trading

Previous close9.38
Today’s open9.55
Day’s range9.26 - 9.57
Volume103,381
Average volume (3 months)273,933
Market cap$440.1M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+8.22%
Earnings growth (next 5 years)-37.30%
Revenue growth (last year)-38.40%
P/E ratioNM
Price/Sales2,290.37
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
TLGTTeligent Inc-0.06-0.76%
AVDLAvadel Pharmaceutica...-0.04-0.38%
MYOKMyoKardia Inc-0.30-2.16%
ACIUAC Immune Ltd+0.06+0.75%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$154.0K
Annual profit (last year)-$109.6M
Net profit margin-71,153.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts